These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 37212261)
21. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218 [TBL] [Abstract][Full Text] [Related]
22. Placental SARS-CoV-2 in a pregnant woman with mild COVID-19 disease. Hsu AL; Guan M; Johannesen E; Stephens AJ; Khaleel N; Kagan N; Tuhlei BC; Wan XF J Med Virol; 2021 Feb; 93(2):1038-1044. PubMed ID: 32749712 [TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
24. The increasing importance of the novel Coronavirus. Mungroo MR; Khan NA; Siddiqui R Hosp Pract (1995); 2021 Feb; 49(1):1-11. PubMed ID: 32990100 [TBL] [Abstract][Full Text] [Related]
25. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494 [TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2 Infection and Significance of Oral Health Management in the Era of "the New Normal with COVID-19". Imai K; Tanaka H Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207046 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of vertical transmission of SARS-CoV-2 in utero: Nine pregnant women and their newborns. Dong L; Pei S; Ren Q; Fu S; Yu L; Chen H; Chen X; Yin M Placenta; 2021 Aug; 111():91-96. PubMed ID: 34217121 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection. Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM Elife; 2022 Jan; 11():. PubMed ID: 35072628 [TBL] [Abstract][Full Text] [Related]
29. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial. Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289 [TBL] [Abstract][Full Text] [Related]
30. COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods. Marofi F; Azizi R; Motavalli R; Vahedi G; Nasimi M; Yousefi M; Motavalli Y; Tahmasebi S; Gharibi T; Mohammed RN; Etemadi J; Khiavi FM Anticancer Agents Med Chem; 2021 Oct; 21(16):2142-2162. PubMed ID: 33563186 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM; Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478 [TBL] [Abstract][Full Text] [Related]
32. Saliva: What Dental Practitioners Should Know about the Role of This Biofluid in the Transmission and Diagnostic of SARS-CoV-2. Casillas Santana MA; Dipp Velázquez FA; Sámano Valencia C; Martínez Zumarán A; Zavala Alonso NV; Martínez Rider R; Salas Orozco MF Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917276 [TBL] [Abstract][Full Text] [Related]
33. JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Inglis TJJ; Mathee K J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33759741 [TBL] [Abstract][Full Text] [Related]
34. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Pan F; Xiao X; Guo J; Song Y; Li H; Patel DP; Spivak AM; Alukal JP; Zhang X; Xiong C; Li PS; Hotaling JM Fertil Steril; 2020 Jun; 113(6):1135-1139. PubMed ID: 32482249 [TBL] [Abstract][Full Text] [Related]
35. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status. Bchetnia M; Girard C; Duchaine C; Laprise C J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421 [TBL] [Abstract][Full Text] [Related]
36. Whole-genome Sequencing to Track Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Nosocomial Outbreaks. Lucey M; Macori G; Mullane N; Sutton-Fitzpatrick U; Gonzalez G; Coughlan S; Purcell A; Fenelon L; Fanning S; Schaffer K Clin Infect Dis; 2021 Jun; 72(11):e727-e735. PubMed ID: 32954414 [TBL] [Abstract][Full Text] [Related]
37. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century. Asrani P; Hasan GM; Sohal SS; Hassan MI OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573 [TBL] [Abstract][Full Text] [Related]
38. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2). Xiang Y; Wang M; Chen H; Chen L Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003 [TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 Transmission among Marine Recruits during Quarantine. Letizia AG; Ramos I; Obla A; Goforth C; Weir DL; Ge Y; Bamman MM; Dutta J; Ellis E; Estrella L; George MC; Gonzalez-Reiche AS; Graham WD; van de Guchte A; Gutierrez R; Jones F; Kalomoiri A; Lizewski R; Lizewski S; Marayag J; Marjanovic N; Millar EV; Nair VD; Nudelman G; Nunez E; Pike BL; Porter C; Regeimbal J; Rirak S; Santa Ana E; Sealfon RSG; Sebra R; Simons MP; Soares-Schanoski A; Sugiharto V; Termini M; Vangeti S; Williams C; Troyanskaya OG; van Bakel H; Sealfon SC N Engl J Med; 2020 Dec; 383(25):2407-2416. PubMed ID: 33176093 [TBL] [Abstract][Full Text] [Related]
40. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future]. Ye ZW; Jin DY Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]